About Precision Neuroscience
Precision Neuroscience is a company based in New York (United States) founded in 2021 by Benjamin Rapoport, Demetrios Papageorgiou, Mark Hettick, and Michael Mager.. Precision Neuroscience has raised $182.65 million across 6 funding rounds from investors including Mubadala, Jdpglobal and General Equity Holdings. The company has 22 employees as of December 31, 2022. Precision Neuroscience offers products and services including Layer 7 Cortical Interface and Processing Unit. Precision Neuroscience operates in a competitive market with competitors including Blackrock Neurotech, Nexstim, MindMaze, INBRAIN Neuroelectronics and Synergia Medical, among others.
- Headquarter New York, United States
- Employees 22 as on 31 Dec, 2022
- Founders Benjamin Rapoport, Demetrios Papageorgiou, Mark Hettick, Michael Mager
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$182.65 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
Mubadala
& 10 more
-
Employee Count
22
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision Neuroscience
Precision Neuroscience offers a comprehensive portfolio of products and services, including Layer 7 Cortical Interface and Processing Unit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Implantable device records brain signals to control digital devices.
Translates recorded brain signals into actionable data for devices.
Funding Insights of Precision Neuroscience
Precision Neuroscience has successfully raised a total of $182.65M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(27 Apr 2021)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series C - Precision Neuroscience | Valuation | SCI Ventures |
|
| Jan, 2025 | Amount | Series C - Precision Neuroscience | Valuation |
investors |
|
| Oct, 2024 | Amount | Series C - Precision Neuroscience | Valuation | General Equity Holdings |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Precision Neuroscience
Precision Neuroscience has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Mubadala, Jdpglobal and General Equity Holdings. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multistage investments are directed toward technology, healthcare, and climate sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precision Neuroscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Precision Neuroscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precision Neuroscience Comparisons
Competitors of Precision Neuroscience
Precision Neuroscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blackrock Neurotech, Nexstim, MindMaze, INBRAIN Neuroelectronics and Synergia Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices for neurological therapies are developed.
|
|
| domain | founded_year | HQ Location |
Noninvasive brain stimulation is provided for stroke patient rehabilitation.
|
|
| domain | founded_year | HQ Location |
Evidence-based digital neurotherapeutics are developed for brain health recovery.
|
|
| domain | founded_year | HQ Location |
AI-based neuroelectronic devices for brain disorder detection are developed.
|
|
| domain | founded_year | HQ Location |
Implantable neurostimulators and contactless monitoring systems are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precision Neuroscience
Frequently Asked Questions about Precision Neuroscience
When was Precision Neuroscience founded?
Precision Neuroscience was founded in 2021.
Where is Precision Neuroscience located?
Precision Neuroscience is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of Precision Neuroscience?
Michael Mager is the current CEO of Precision Neuroscience. They have also founded this company.
Is Precision Neuroscience a funded company?
Precision Neuroscience is a funded company, having raised a total of $182.65M across 6 funding rounds to date. The company's 1st funding round was a Series C of $102M, raised on Apr 27, 2021.
How many employees does Precision Neuroscience have?
As of Dec 31, 2022, the latest employee count at Precision Neuroscience is 22.
What does Precision Neuroscience do?
Precision Neuroscience was founded in 2021 in New York, United States, within the neuroscience sector. Brain-computer interface technologies are created by the company for applications in medical treatments and drug development. Operations focus on implants that enable AI-based computing, device integration, and neurological assessments. These tools support evaluations of illnesses and advancements in therapeutic solutions.
Who are the top competitors of Precision Neuroscience?
Precision Neuroscience's top competitors include Blackrock Neurotech, INBRAIN Neuroelectronics and Nexstim.
What products or services does Precision Neuroscience offer?
Precision Neuroscience offers Layer 7 Cortical Interface and Processing Unit.
Who are Precision Neuroscience's investors?
Precision Neuroscience has 11 investors. Key investors include Mubadala, Jdpglobal, General Equity Holdings, B Capital, and Duquesne Family Office.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.